p27^Kip1 V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor–positive breast cancer.

Autor: Mouron, Silvana, Bueno, Maria J, Muñoz, Manuel, Torres, Raul, Rodríguez, Sandra, Apala, Juan V, Silva, Jorge, Sánchez-Bayona, Rodrigo, Manso, Luis, Guerra, Juan, Rodriguez-Lajusticia, Laura, Malon, Diego, Malumbres, Marcos, Quintela-Fandino, Miguel

Publikováno v: JNCI Cancer Spectrum; Apr2023, Vol. 7 Issue 2, p1-5, 5p

Additional file 2 of Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial

Autor: Quintela-Fandino, Miguel, Holgado, Esther, Manso, Luis, Morales, Serafin, Bermejo, Begoña, Colomer, Ramon, Apala, Juan V., Blanco, Raquel, Muñoz, Manuel, Caleiras, Eduardo, Iranzo, Vega, Martinez, Mario, Dominguez, Orlando, Hornedo, Javier, Gonzalez-Cortijo, Lucia, Cortes, Javier, Cudos, Ariadna Gasol, Malon, Diego, Lopez-Alonso, Antonio, Moreno-Ortíz, María C., Mouron, Silvana, Mañes, Santos

Additional file 2 : Supplementary Figure S2: Flow cytometry gating strategy for Treg cells. Representative gating strategy used in Treg cell immunophenotyping based on the exclusion of dead cells, the selection of the lymphoid cells by size and compl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50e2d7c3dee7a308a23d482b9a725b1a

Additional file 3 of Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial

Autor: Quintela-Fandino, Miguel, Holgado, Esther, Manso, Luis, Morales, Serafin, Bermejo, Begoña, Colomer, Ramon, Apala, Juan V., Blanco, Raquel, Muñoz, Manuel, Caleiras, Eduardo, Iranzo, Vega, Martinez, Mario, Dominguez, Orlando, Hornedo, Javier, Gonzalez-Cortijo, Lucia, Cortes, Javier, Cudos, Ariadna Gasol, Malon, Diego, Lopez-Alonso, Antonio, Moreno-Ortíz, María C., Mouron, Silvana, Mañes, Santos

Additional file 3 : Supplementary Figure S3: Flow cytometry gating strategy for innate cell populations. Representative example of the gating strategy used for immunophenotyping of the indicated innate subpopulations. After the exclusion of dead cell

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ba730fd53df163512d9340ed829597d

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer

Autor: Zagorac, Ivana, Fernandez-Gaitero, Sara, Penning, Renske, Post, Harm, Bueno, Maria J, Mouron, Silvana, Manso, Luis, Morente, Manuel M, Alonso, Soledad, Serra, Violeta, Muñoz, Javier, Gómez-López, Gonzalo, Lopez-Acosta, Jose Francisco, Jimenez-Renard, Veronica, Gris-Oliver, Albert, Al-Shahrour, Fatima, Piñeiro-Yañez, Elena, Montoya-Suarez, Jose Luis, Apala, Juan V, Moreno-Torres, Amalia, Colomer, Ramon, Dopazo, Ana, Heck, Albert J R, Altelaar, Maarten, Quintela-Fandino, Miguel, Afd Biomol.Mass Spect. and Proteomics, Sub Biomol.Mass Spectrometry & Proteom., Biomolecular Mass Spectrometry and Proteomics

Publikováno v: Nature Communications, 9(1). Nature Publishing Group
Nature Communications
Repisalud
Instituto de Salud Carlos III (ISCIII)
Nature Communications, Vol 9, Iss 1, Pp 1-15 (2018)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

Triple-negative breast cancer (TNBC) lacks prognostic and predictive markers. Here, we use high-throughput phosphoproteomics to build a functional TNBC taxonomy. A cluster of 159 phosphosites is upregulated in relapsed cases of a training set (n = 34

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88c8a855b1e2158f8514c0b755f2e3fb
https://dspace.library.uu.nl/handle/1874/370801